sorry, we can't preview this file
Subcutaneous immunoglobulin use in immunoglobulin-naïve patients with primary immunodeficiency: a systematic review. Supplementary tables.
Supplementary Table 1. Search strategies A. Embase search strategy performed March 29, 2021. Limits: February 1, 2019 – March 29, 2021 B. MEDLINE search strategy performed March 29, 2021. Limits: February 1, 2019 – March 29, 2021 C. Cochrane Library search strategy performed March 29, 2021. Limits: February 1, 2019 – March 29, 2021 D. BIOSIS search strategy (ProQuest Dialog Platform) performed March 30, 2021. Limits: February 1, 2019 – March 30, 2021 E. Search Results, by Database: Supplementary Searches; Search performed on March 29, 2021. Limits: February 2, 2019 to present F. Results of registry searches; March 29, 2021 Supplementary Table 2. COMPLETED PRISMA CHECKLIST Supplementary Table 3. Details of SCIG-dosing regimens or patient health and treatment pathways in IG-naïve patients Supplementary Table 4. Information on Loading Regimens From the Available Studies Supplementary Table 5. Summary of Quality of Included Studies |